SCHEMBL26870697

SCHEMBL26870697

CCN(C(C)C)S(=O)(=O)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13100468 0.82
SCHEMBL15625950 0.79
SCHEMBL10112133 0.78 CA12 (0.32)
SCHEMBL15202723 0.74 TP53 (0.34) VCAM1
SCHEMBL13379960 0.74 VCAM1 (0.33) VCAM1
SCHEMBL777525 0.74 SMN1; SMN2 (0.34)
SCHEMBL25477051 0.72 TP53 (0.33) VCAM1
SCHEMBL16732570 0.72 CA2 (0.40) VCAM1
SCHEMBL13301125 0.72
SCHEMBL25927506 0.69 ALOX5 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381180-A1 SMALL MOLECULE MODULATORS OF KSR-BOUND MEK ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381180-A1 SMALL MOLECULE MODULATORS OF KSR-BOUND MEK KSR1, KSR2, BRAF VCAM1 4405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.